Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2282994
Max Phase: Preclinical
Molecular Formula: C13H12F3N5OS
Molecular Weight: 343.33
Molecule Type: Small molecule
Associated Items:
ID: ALA2282994
Max Phase: Preclinical
Molecular Formula: C13H12F3N5OS
Molecular Weight: 343.33
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CN(C)c1ccc(/C=N/NC(=O)c2snnc2C(F)(F)F)cc1
Standard InChI: InChI=1S/C13H12F3N5OS/c1-21(2)9-5-3-8(4-6-9)7-17-19-12(22)10-11(13(14,15)16)18-20-23-10/h3-7H,1-2H3,(H,19,22)/b17-7+
Standard InChI Key: OBSUVXYWOUUKEN-REZTVBANSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 343.33 | Molecular Weight (Monoisotopic): 343.0715 | AlogP: 2.39 | #Rotatable Bonds: 4 |
Polar Surface Area: 70.48 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 8.43 | CX Basic pKa: 4.15 | CX LogP: 3.06 | CX LogD: 3.02 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.68 | Np Likeness Score: -2.34 |
1. Sambasiva Rao P, Kurumurthy C, Veeraswamy B, Santhosh kumar G, Narsaiah B, Pranay Kumar K, Murthy USN, Karnewar S, Kotamraju S. (2013) Synthesis, antimicrobial and cytotoxic activities of novel 4-trifluoromethyl-(1,2,3)-thiadiazolo-5-carboxylic acid hydrazide Schiffs bases, 22 (4): [10.1007/s00044-012-0168-x] |
Source(1):